SPDR S&P Pharmaceuticals ETF Rating → You won't believe what Citigroup just did to it's depositors (From American Alternative) (Ad) Free XPH Stock Alerts $40.01 -0.29 (-0.72%) (As of 12:47 PM ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy2.65Holdings in XPH have an aggregate rating of Moderate Buy based on 298 analyst ratings issued in the past year covering 40 companies (98.7% of the portfolio).XPH Aggregate Price Target$66.7466.81% UpsideHigh Prediction$86.15Average Prediction$66.74Low Prediction$47.46Holdings in XPH have an aggregate price target of $66.74 and a range of $47.46 to $86.15 covering 40 companies (98.7% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 XPH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.51%OGNOrganon & Co.$20.81-0.8%5 of 5 stars2.50$22.60 8.6%4Short Interest ↓5.02%PFEPfizer$27.86-1.6%5 of 5 stars2.40$35.86 28.7%155.01%MRKMerck & Co., Inc.$125.84-0.2%4 of 5 stars2.58$131.33 4.4%12News Coverage4.94%AXSMAxsome Therapeutics$73.84-3.8%5 of 5 stars2.92$121.92 65.1%13Positive News4.88%ELANElanco Animal Health$17.48+2.0%3 of 5 stars2.57$18.29 4.6%7Short Interest ↑News Coverage4.78%LLYEli Lilly and Company$808.50+0.1%5 of 5 stars2.84$769.53 -4.8%19Insider Selling4.66%ITCIIntra-Cellular Therapies$66.20+0.9%4 of 5 stars2.90$90.17 36.2%10Short Interest ↑4.63%PRGOPerrigo$26.96-1.4%5 of 5 stars3.00$40.67 50.8%3Analyst UpgradeShort Interest ↑Analyst Revision4.62%CTLTCatalent$53.980.0%3 of 5 stars2.17$53.14 -1.6%12Analyst ForecastNews Coverage4.57%JNJJohnson & Johnson$144.60+0.2%5 of 5 stars2.46$175.86 21.6%134.50%ZTSZoetis$172.30+0.6%5 of 5 stars3.00$211.75 22.9%7Dividend AnnouncementShort Interest ↑Analyst Revision4.44%JAZZJazz Pharmaceuticals$103.74-1.3%5 of 5 stars2.85$192.75 85.8%13Positive News4.34%RPRXRoyalty Pharma$26.43-0.8%5 of 5 stars3.00$46.75 76.9%4Positive News4.25%VTRSViatris$10.34-0.5%1 of 5 stars1.33$11.00 6.4%3Insider Selling3.99%CORTCorcept Therapeutics$31.84+0.7%5 of 5 stars3.00$40.10 25.9%4Analyst ForecastNews CoveragePositive News3.87%BMYBristol-Myers Squibb$40.46-0.1%5 of 5 stars2.11$60.00 48.3%19Analyst Revision2.42%ARVNArvinas$34.36-2.5%2 of 5 stars2.88$61.13 77.9%16Positive News2.16%AMPHAmphastar Pharmaceuticals$41.80-0.4%5 of 5 stars2.50$66.00 57.9%4Short Interest ↓Analyst RevisionPositive News2.00%SAVACassava Sciences$21.59-0.4%4 of 5 stars3.00$131.00 506.8%1Positive NewsGap Down1.96%TARSTarsus Pharmaceuticals$34.56+0.6%3 of 5 stars2.88$50.38 45.8%81.44%PCRXPacira BioSciences$29.43-2.1%5 of 5 stars3.00$47.40 61.1%10Short Interest ↑1.41%EYPTEyePoint Pharmaceuticals$10.62-4.6%2 of 5 stars3.00$33.71 217.5%7Short Interest ↑Positive News1.30%PBHPrestige Consumer Healthcare$62.90-0.4%5 of 5 stars2.50$91.25 45.1%41.22%LBPHLongboard Pharmaceuticals$18.34-1.7%1 of 5 stars3.00$43.67 138.1%6Positive NewsGap Up1.13%HRMYHarmony Biosciences$29.25-0.6%4 of 5 stars2.50$40.63 38.9%8Short Interest ↑1.02%COLLCollegium Pharmaceutical$33.29-3.1%3 of 5 stars2.20$39.00 17.2%5Insider Selling0.97%LQDALiquidia$12.293 of 5 stars2.60$21.00 70.9%5Positive News0.95%AMRXAmneal Pharmaceuticals$6.77-0.3%1 of 5 stars3.00$8.25 21.9%4Short Interest ↑Gap Down0.94%LGNDLigand Pharmaceuticals$84.65-1.5%5 of 5 stars3.00$116.33 37.4%3Positive News0.91%AMLXAmylyx Pharmaceuticals$1.67-2.6%4 of 5 stars2.25$28.67 1,621.7%8Short Interest ↓Positive News0.85%SUPNSupernus Pharmaceuticals$26.60-1.7%4 of 5 stars3.00$41.00 54.1%10.73%PLRXPliant Therapeutics$12.79-0.7%4 of 5 stars3.00$45.38 254.8%9Positive News0.60%ANIPANI Pharmaceuticals$62.68-0.9%5 of 5 stars3.00$81.00 29.2%4Short Interest ↓Positive News0.53%EOLSEvolus$12.60-0.2%4 of 5 stars3.00$21.25 68.7%30.51%RVNCRevance Therapeutics$2.81+5.2%4 of 5 stars2.50$11.50 309.3%80.45%OCULOcular Therapeutix$5.83-1.7%4 of 5 stars2.83$15.17 160.1%6News CoveragePositive News0.40%XERSXeris Biopharma$1.93+0.5%4 of 5 stars3.00$4.63 139.6%4Positive NewsGap Down0.39%TBPHTheravance Biopharma$8.29-1.4%2 of 5 stars3.00$20.50 147.3%2Analyst DowngradeNews Coverage0.29%FULCFulcrum Therapeutics$7.69-0.6%3 of 5 stars3.00$15.57 102.5%7Gap Up0.06%MRNSMarinus Pharmaceuticals$1.52+1.3%4 of 5 stars2.57$13.79 807.0%7Gap Down This page (NYSEARCA:XPH) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWrite this ticker symbol down…StocksToTradeNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
